Farmacoeconomía del tratamiento de las candidiasis invasoras
Authors:
- Santiago Grau-CerratoSantiago Grau-Cerrato
- Olivia Ferrández-QuiranteOFOlivia Ferrández-Quirante
- 1 March 2009
- journal article
- review article
- Published by Elsevier in Revista Iberoamericana de Micologia
- Vol. 26 (1) , 90-93
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Candidemia in the 21st CenturyFuture Microbiology, 2008
- Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infectionsDiagnostic Microbiology and Infectious Disease, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- The Changing Face of Fungal Infections in Health Care SettingsClinical Infectious Diseases, 2005
- Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003Journal of Clinical Microbiology, 2005
- Economic Impact of Candida Colonization and Candida Infection in the Critically Ill PatientEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance ProgramJournal of Clinical Microbiology, 2001
- National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, Issued June 1999American Journal of Infection Control, 1999
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of IllnessClinical Infectious Diseases, 1998